Psychoeducational multi-family group treatment with adolescents at high risk for developing psychosis

Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California 90095, USA.
Early Intervention in Psychiatry (Impact Factor: 1.95). 11/2007; 1(4):325-32. DOI: 10.1111/j.1751-7893.2007.00046.x
Source: PubMed


In this study, we investigate the feasibility and acceptability of a 9-month psychoeducational multi-family group (PMFG) intervention for adolescents who are at ultra-high-risk (UHR) for developing psychosis.
The treatment programme was adapted from those previously shown to be effective in patients with established psychotic illness, but emphasizes content relevant to adolescence and to a pre-onset phase of illness.
Participants report that psychoeducational presentations are highly useful, they attend the PMFG group sessions regularly and report feeling comfortable in meetings and benefiting from them, and adolescents demonstrate improvement in symptoms and functional outcome.
This study was not a randomized controlled trial and multiple interventions were introduced simultaneously; thus, changes in outcome cannot be attributed to the PMFG intervention per se. Nonetheless, these results establish the acceptability of PMFG to adolescents and families, and encourage further research into the potential positive impact of PMFG with this at-risk population.

Download full-text


Available from: Carrie E Bearden, Dec 01, 2014
  • Source
    • "6 EG: 17% CG: 25% TR (SIPS), FO (GAF) O'Brien et al., 2007 [87] "
    [Show abstract] [Hide abstract]
    ABSTRACT: This guidance paper from the European Psychiatric Association (EPA) aims to provide evidence-based recommendations on early intervention in clinical high risk (CHR) states of psychosis, assessed according to the EPA guidance on early detection. The recommendations were derived from a meta-analysis of current empirical evidence on the efficacy of psychological and pharmacological interventions in CHR samples. Eligible studies had to investigate conversion rate and/or functioning as a treatment outcome in CHR patients defined by the ultra-high risk and/or basic symptom criteria. Besides analyses on treatment effects on conversion rate and functional outcome, age and type of intervention were examined as potential moderators. Based on data from 15 studies (n=1394), early intervention generally produced significantly reduced conversion rates at 6- to 48-month follow-up compared to control conditions. However, early intervention failed to achieve significantly greater functional improvements because both early intervention and control conditions produced similar positive effects. With regard to the type of intervention, both psychological and pharmacological interventions produced significant effects on conversion rates, but not on functional outcome relative to the control conditions. Early intervention in youth samples was generally less effective than in predominantly adult samples. Seven evidence-based recommendations for early intervention in CHR samples could have been formulated, although more studies are needed to investigate the specificity of treatment effects and potential age effects in order to tailor interventions to the individual treatment needs and risk status. Copyright © 2015 Elsevier Masson SAS. All rights reserved.
    European Psychiatry 03/2015; 30:388-404. DOI:10.1016/j.eurpsy.2015.01.013 · 3.44 Impact Factor
  • Source
    • "Small single-arm feasibility studies examining the effectiveness of psychoeducation have produced mixed results. A 9-month multi-family group treatment reported significant improvement in global and role functioning, in conjunction with improved positive and general symptoms (O'Brien et al., 2007). However, most participants (81%) were also receiving medication, and all were receiving additional psychological therapies. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Transition to psychotic disorder has been the traditional outcome of interest for research in the at-risk mental state (ARMS). However, there is growing recognition that individuals with ARMS may function poorly regardless of whether they develop psychosis. We aimed to review the literature to determine whether there are specific factors associated with, or predictive of, functional impairment in the ARMS population. Method: An electronic database search of MEDLINE, PsycINFO and Embase from inception until May 2014 was conducted using keyword search terms synonymous with the at-risk mental state and functioning. Eligible studies were original peer-reviewed English language research articles with populations that met validated at-risk diagnostic criteria and examined the cross-sectional or longitudinal association between any variable and a measure of functioning. Results: Seventy-two eligible studies were identified. Negative symptoms and neurocognitive impairment were associated with poor functioning in cross-sectional studies. Negative and disorganised symptoms, neurocognitive deficits and poor functioning at baseline were predictive of poor functional outcome in longitudinal studies. Positive symptoms were unrelated to functioning in both cross-sectional and longitudinal studies. Functional disability was persistent and resistant to current treatments. Conclusions: Negative and disorganised symptoms and cognitive deficits pre-date frank psychotic symptoms and are risk factors for poor functioning. This is consistent with a subgroup of ARMS individuals potentially having neurodevelopmental schizophrenia. Treatments aimed at improving functioning must be considered a priority on par with preventing transition to psychosis in the development of future interventions in the ARMS group.
    Schizophrenia Research 09/2014; 159(2-3). DOI:10.1016/j.schres.2014.09.012 · 3.92 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mit der indizierten Prävention bei Personen mit erhöhtem Psychoserisiko verbindet sich die Hoffnung, eine manifeste psychotische Erkrankung hinauszuzögern oder sogar den Übergang in das Vollbild der Erkrankung zu verhindern. Aber auch die Remission der Risikosymptomatik, das psychosoziale Funktionsniveau und die Lebensqualität sind weitere Zielgrößen. Kognitive Verhaltenstherapie kann zurzeit als der am besten evaluierte und statistisch abgesicherte Einzeltherapieansatz bezüglich der Psychoseprävention gelten. Grundsätzlich ist die Behandlung von Personen mit erhöhtem Psychoserisiko mit dem Risiko verbunden, fälschlich-identifizierte Personen potenziellen Nebenwirkungen auszusetzen. Daher sollte immer die Behandlung mit dem besten Risiko-Nutzen-Verhältnis gewählt werden. Folglich sollte vor einer intensiveren Behandlung zunächst das Monitoring in Früherkennungszentren, gefolgt von einer angepassten Psychoedukation erwogen werden. Die Datenlage im Hinblick auf die Psychoedukation von Risikopersonen ist zwar ermutigend, aber noch nicht ausreichend. Methodische Aspekte, Schwerpunkte und Unterschiede in den evaluierten Ansätzen werden diskutiert.
    Psychotherapeut 07/2013; 58(4). DOI:10.1007/s00278-013-0996-2 · 0.78 Impact Factor
Show more